| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | AYTU Aytu Biopharma, Inc | Disbrow Joshua R.57 | Chief Executive Officer | Buy | 112,371 | $0.22 | $25,047.50 | +10.0% | -53.3% | -33.9% | |
| Dec 19, 2022 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 10,044 | $6.72 | $67,495.68 | -100% | +44.4% | +30.8% | |
| Dec 19, 2022 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 13,744 | $6.72 | $92,359.68 | -4.4% | +44.4% | +30.8% | |
| Dec 19, 2022 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 6,445 | $6.72 | $43,310.40 | -36.4% | +44.4% | +30.8% | |
| Dec 19, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $274.21 | $4,387,354.36 | -26.3% | -17.1% | -11.6% | |
| Dec 16, 2022 | PRGO Perrigo Co Plc | Quinn Grainne | EVP, Chief Medical Officer | Sell | 2,368 | $31.65 | $74,947.20 | -20.6% | +13.3% | -7.2% | |
| Dec 16, 2022 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 60,000 | $19.69 | $1,181,497.75 | -51.3% | -3.0% | -83.8% | |
| Dec 16, 2022 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 4,837 | $6.74 | $32,601.38 | -1.5% | +47.2% | +25.0% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Jones Michael L74 | Exec. Director, Finance - Pao | Sell | 445 | $10.90 | $4,850.50 | -4.0% | -22.6% | -42.7% | |
| Dec 15, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 12,000 | $196.31 | $2,355,721.65 | -5.0% | -21.2% | -10.7% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Barnes Alane P70 | Chief Legal Officer | Sell | 4,175 | $10.88 | $45,424.00 | -2.1% | -22.6% | -42.7% | |
| Dec 15, 2022 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $53.75 | $20,747.50 | -0.6% | +38.9% | +44.2% | |
| Dec 15, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $275.36 | $2,202,893.36 | -22.6% | -21.2% | -10.7% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Stonehouse Jon P80 | President &CEO | Sell | 14,100 | $10.90 | $153,690.00 | -1.6% | -22.6% | -42.7% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Gayer Charles K | Chief Commercial Officer | Sell | 6,100 | $10.90 | $66,490.00 | -2.8% | -22.6% | -42.7% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Thackray Helen M.78 | Chief R&D Officer | Sell | 3,125 | $10.89 | $34,031.25 | -2.3% | -22.6% | -42.7% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Doyle Anthony70 | Chief Financial Officer | Sell | 5,700 | $10.90 | $62,130.00 | -3.4% | -22.6% | -42.7% | |
| Dec 15, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 204,188 | $2.82 | $575,185.12 | +7.6% | -30.7% | -31.1% | |
| Dec 14, 2022 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,000 | $7.34 | $14,680.00 | -0.6% | +20.7% | +21.1% | |
| Dec 14, 2022 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 431,183 | $10.52 | $4,536,045.16 | +12.9% | +46.8% | -22.6% | |
| Dec 14, 2022 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 27,000 | $12.39 | $334,530.00 | -7.2% | -13.5% | -7.7% | |
| Dec 14, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $277.37 | $4,437,990.62 | -40.1% | -20.3% | -8.2% | |
| Dec 13, 2022 | JNJ Johnson & Johnson | Wolk Joseph J | Exec VP, CFO | Sell | 14,781 | $179.60 | $2,654,660.91 | -14.9% | -14.6% | -13.1% | |
| Dec 13, 2022 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 9,698 | $3.77 | $36,534.31 | -57.1% | - | - | |
| Dec 13, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 174,152 | $2.89 | $503,958.26 | +7.5% | -31.2% | -31.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.